Navigation Links
Cola May Be Bad to the Bones
Date:4/26/2008

ew">National Osteoporosis Foundation.



SOURCES: Lawrence Raisz, M.D., director, University of Connecticut Center for Osteoporosis, Farmington; Primal Kaur, M.D., rheumatologist, and director, Osteoporosis Center, Temple University Health Sciences Center, Philadelphia; American Journal of Clinical Nutrition


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New IOF Report Shows Smoking, Alcohol, Being Underweight and Poor Nutrition Harm Our Bones
2. Some Female Athletes Risking Weaker Bones
3. High-Trauma Fractures Tied to Weak Bones
4. Diabetes Drug Avandia Could Weaken Bones
5. Dads break bones of children more often than moms
6. Stem cell treatment for brittle bones in the womb
7. Scientists move towards stem cell therapy trials to mend shattered bones
8. Potential brain cancer drug for children may damage bones
9. Potential Brain Cancer Drug for Children May Damage Bones
10. Good luck indeed: 53 million-year-old rabbits foot bones found
11. Bones mend faster without marrow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
... the number of foreign-born health care workers in... for transmitting tuberculosis in health-care sett...e experts Timothy R. Sterling, M.D., and David W. ...ed to health care workers with latent TB infection...
...arma company Venus Remedies Ltd today said it has ...or its latest antibiotic fixed dose combination us...w antibiotic combination, active against multi-res...and gram-negative bacteria and provides a broad-sp...
...ny adults who consider suicide fail to seek help f...en those who do ask for help may find it difficult...ording to a new study. "We need to improve access...ideation," said Ruth Klap, Ph.D., a sociologist at...
...e UNICEF has urged that the orphans and vulnerable...al fight against HIV/AIDS.// In their new report... AIDS', Unicef called for renewed vigour to tackle...realize the targets chartered in the UN Millennium...
Other Medicine News:Health News:Many Suicidal Adults Aren't Getting Mental Health Treatment 2
(Date:9/4/2008)...wswire/ -- Southern Research Institute,today annou...has selected,the organization to participate in th...n Center Network (MLPCN). The MLPCN -- a collabora...Libraries Program which is,designed to benefit hum...an,genome and validate future targets for drug dis...
(Date:9/4/2008)...4 /- Axentis Pharma AG has,initiated ...d tolerability,of a new therapeutic formulation fo...ystic fibrosis patients. The new formulation allow... directly to the site of,infection. The forthcomin...rent doses of the new drug. Initial results are ex...
(Date:9/4/2008)... antiviral activity and favorable safety ... Sept. 4 /- Idenix,Pharmace...l company engaged,in the discovery and development...er infectious diseases, today announced that it ha...IDX899, a non-nucleoside reverse,transcriptase inh...
(Date:9/4/2008)...edule with Two Abstracts Accepted for Presenta...2008, BRIDGEWATER, N.J., Sept. 4 /- ...ceutical company focused on the treatment of,cardi...he appointment of,Peter L. Garrambone, Jr. to the ... career includes more than 50 pharmaceutical,trans...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30 2008 4886 1Bypassing the insulin highway 3061 1FDA Examines Quality of Life for LASIK Patients 17784 1FDA Examines Quality of Life for LASIK Patients 17784 2FDA Examines Quality of Life for LASIK Patients 17784 3Engaging Health Care Consumers Online is Top Priority 17780 1Engaging Health Care Consumers Online is Top Priority 17780 2Engaging Health Care Consumers Online is Top Priority 17780 3
...eet Primary Endpoint of Improvement in Overall,Sur...re-FirstCall/ --,Allos Therapeutics, Inc. today an...s pivotal Phase 3 study of Efaproxyn ,(efaproxiral...en,with brain metastases originating from breast c...point of demonstrating a,statistically significant...
... 20, 2007 /PRNewswire-FirstCall/ -- Anadys,Pharmac...tted to,the discovery, development and commerciali...atitis and cancer, announced today that it,has nom...ent as an,orally-administered direct antiviral for...infection. , "We have identified a small-molecule,...
Other Medicine Technology:Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat
Angled shaft with 1.5 mm tip designed to efficiently perform the "Stop and Chop" technique. Round knurled handle. Most popular size or model.
This double ended instrument was designed for delineating and lifting the corneal flap of previously performed lamellar refractive surgery cases.
Used when dislocating the lens. Great for chopping during phacoemulsification. Helpful in ushering the IOL out of eye. Useful to reduce possibility of iris tuck with anterior chamber IOL placement.
Medicine Products: